Saul Rodriguez


I am currenly working on developing novel therapies for temporal lobe epilepsy in a  kainic acid-induced model of epilepsy. The injury creates neurological changes that promote the production of proinflammatory cytokines which result in free radicals products, neurodegeneration, and gliosis. Together they create an overarching neuroinflammation that promotes the development of epilepsy. By attenuating this neuroinflammation, my hope is to prevent the progression of epilepsy altogether.


Saul Rodriguez
Hometown: Stanton, CA
BS, Pharmaceutical Sciences, University of California - Irvine